| Line Item | 2023-12-31 | Y/Y |
|---|---|---|
| Revenue | $388.1M | -15.4% |
| Cost of Revenue | $321.4M | -17.4% |
| R&D Expense | $18.5M | -12.4% |
| SG&A Expense | $62.7M | +12.9% |
| Operating Income | -$39.9M | -12.8% |
| Interest Expense | $15.3M | +65.7% |
| Pre-tax Income | -$57.0M | -287.2% |
| Income Tax | -$463K | -100.4% |
| Net Income | -$40.4M |
| Line Item | 2023-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $17.3M | +18.8% |
| Accounts Receivable | $53.8M | -10.4% |
| Current Assets | $74.6M | -7.3% |
| Total Assets | $153.9M | -9.5% |
| Current Liabilities | $79.7M | +3.7% |
| Long-term Debt | $174.3M | -4.8% |
| Total Liabilities | $248.3M | -3.1% |
| Line Item | 2023-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | $20.2M | -28.4% |
| Investing Cash Flow | -$73K | +99.9% |
| Financing Cash Flow | -$17.4M | -20.0% |
| +29.9% |
| EPS (Basic) | -$0.89 | +35.0% |
| EPS (Diluted) | -$0.89 | +35.0% |
| Stockholders' Equity |
| -$10.3M |
| +35.6% |